ORTHOPEDIATRICS CORP

OrthoPediatrics Corp. designs, develops, and markets orthopedic implants, instruments, and specialized braces tailored specifically for children with musculoskeletal conditions. The company's product portfolio addresses three primary clinical areas: pediatric trauma and deformity correction, scoliosis treatment for spinal deformity, and sports medicine applications. Representative products include the PediLoc fixation system, PediFlex and PediNail intramedullary nailing platforms, the RESPONSE Spine system for scoliosis procedures, the GIRO Growth Modulation System, and the Boston Brace 3D. The company also offers the Fassier-Duval Telescopic Intramedullary System and ApiFix Mid-C System, among other specialized devices designed around pediatric anatomical requirements.

The company operates primarily within the pediatric orthopedic market, serving orthopedic surgeons and caregivers in the United States and internationally. OrthoPediatrics maintains manufacturing and operational headquarters in Warsaw, Indiana, with a workforce of 562 full-time employees. Founded in 2006, the company is publicly traded on the Nasdaq under the ticker KIDS and maintains a market capitalization of approximately $0.4 billion.